Mobile

A 24-week, open, multicenter, comparative study of 2 strategies (including insulin glargine versus premixed insulin) for the therapeutic management of patients with type 2 diabetes failing oral agents

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-018172-33

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to demonstrate the superiority of a strategy with insulin glargine in comparison with a strategy including the premixed insulin in term of percentage of patients reaching HbA1c below 7% at the end of the treatment period and who do not experience documented symptomatic hypoglycemia (confirmed by a Plasma Glucose (PG) ≤56 mg/dL (3.1 mmol/L)) over the treatment period, in Type 2 diabetes patients failing lifestyle management and oral agents.

Critère d'inclusion

  • Type 2 diabetes failing lifestyle management and oral agents

Liens